BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chu C, Li D, Zhang S, Ikejima T, Jia Y, Wang D, Xu F. Role of silibinin in the management of diabetes mellitus and its complications. Arch Pharm Res 2018;41:785-96. [DOI: 10.1007/s12272-018-1047-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Dinić S, Arambašić Jovanović J, Uskoković A, Mihailović M, Grdović N, Tolić A, Rajić J, Đorđević M, Vidaković M. Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management. Front Endocrinol 2022;13:1006376. [DOI: 10.3389/fendo.2022.1006376] [Reference Citation Analysis]
2 Maleki N, Khosh Ravesh R, Salehiyeh S, Faisal Faiz A, Ebrahimi M, Sharbati A, Panji M, Ajami Khiyavi H, Safizadeh F, Abbasi M, Abazari O, Norbakhsh R, Eskandari Y. Comparative effects of estrogen and silibinin on cardiovascular risk biomarkers in ovariectomized rats. Gene 2022;823:146365. [PMID: 35257789 DOI: 10.1016/j.gene.2022.146365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 García-Viñuales S, Ilie IM, Santoro AM, Romanucci V, Zarrelli A, Di Fabio G, Caflisch A, Milardi D. Silybins inhibit human IAPP amyloid growth and toxicity through stereospecific interactions. Biochim Biophys Acta Proteins Proteom 2022;1870:140772. [PMID: 35307557 DOI: 10.1016/j.bbapap.2022.140772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang H, Zhu J, Jia Z, Lu S. Pretreatment of diabetic aged rats with combination of ginsenoside-Mc1 and silibinin protects liver from ischemia-reperfusion injury through an AMPK-dependent mechanism. Turkish Journal of Biochemistry 2022;47:23-32. [DOI: 10.1515/tjb-2021-0010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chi M, Zhang H, Wang Y, Sun X, Yang Q, Guo C, Sakuma K. Silibinin Alleviates Muscle Atrophy Caused by Oxidative Stress Induced by Cisplatin through ERK/FoxO and JNK/FoxO Pathways. Oxidative Medicine and Cellular Longevity 2022;2022:1-22. [DOI: 10.1155/2022/5694223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Soleymani S, Ayati MH, Mansourzadeh MJ, Namazi N, Zargaran A. The effects of Silymarin on the features of cardiometabolic syndrome in adults: A systematic review and meta-analysis. Phytother Res 2022. [PMID: 35016260 DOI: 10.1002/ptr.7364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 He M, Xia L, Li J. Potential Mechanisms of Plant-Derived Natural Products in the Treatment of Cervical Cancer. Biomolecules 2021;11:1539. [PMID: 34680171 DOI: 10.3390/biom11101539] [Reference Citation Analysis]
8 Zhang J, Shi Q, Hu Y, Li X. Silibinin augments the effect of clopidogrel on atherosclerosis in diabetic ApoE deficiency mice. Clin Hemorheol Microcirc 2021. [PMID: 34602463 DOI: 10.3233/CH-211279] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Issinger OG, Guerra B. Phytochemicals in cancer and their effect on the PI3K/AKT-mediated cellular signalling. Biomed Pharmacother 2021;139:111650. [PMID: 33945911 DOI: 10.1016/j.biopha.2021.111650] [Reference Citation Analysis]
10 Rahmani B, Gandhi J, Joshi G, Smith NL, Reid I, Khan SA. The Role of Diabetes Mellitus in Diseases of the Gallbladder and Biliary Tract. Curr Diabetes Rev 2020;16:931-48. [PMID: 32133965 DOI: 10.2174/1573399816666200305094727] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Tuli HS, Mittal S, Aggarwal D, Parashar G, Parashar NC, Upadhyay SK, Barwal TS, Jain A, Kaur G, Savla R, Sak K, Kumar M, Varol M, Iqubal A, Sharma AK. Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance. Semin Cancer Biol 2021;73:196-218. [PMID: 33130037 DOI: 10.1016/j.semcancer.2020.09.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Sayed AM, Hassanein EH, Salem SH, Hussein OE, Mahmoud AM. Flavonoids-mediated SIRT1 signaling activation in hepatic disorders. Life Sciences 2020;259:118173. [DOI: 10.1016/j.lfs.2020.118173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
13 Diukendjieva A, Zaharieva MM, Mori M, Alov P, Tsakovska I, Pencheva T, Najdenski H, Křen V, Felici C, Bufalieri F, Di Marcotullio L, Botta B, Botta M, Pajeva I. Dual SMO/BRAF Inhibition by Flavonolignans from Silybum marianum . Antioxidants (Basel) 2020;9:E384. [PMID: 32380762 DOI: 10.3390/antiox9050384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
14 Kaur G, Krishan P. Understanding Serotonin 5-HT2A Receptors-regulated cellular and molecular Mechanisms of Chronic Kidney Diseases. Ren Replace Ther 2020;6. [DOI: 10.1186/s41100-020-00268-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chu C, Gao X, Li X, Zhang X, Ma R, Jia Y, Li D, Wang D, Xu F. Involvement of Estrogen Receptor-α in the Activation of Nrf2-Antioxidative Signaling Pathways by Silibinin in Pancreatic β-Cells. Biomol Ther (Seoul) 2020;28:163-71. [PMID: 31649209 DOI: 10.4062/biomolther.2019.071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
16 Liu P, Cui L, Liu B, Liu W, Hayashi T, Mizuno K, Hattori S, Ushiki-kaku Y, Onodera S, Ikejima T. Silibinin ameliorates STZ-induced impairment of memory and learning by up- regulating insulin signaling pathway and attenuating apoptosis. Physiology & Behavior 2020;213:112689. [DOI: 10.1016/j.physbeh.2019.112689] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
17 Liu K, Zhou S, Liu J, Wang Y, Zhu F, Liu M. Silibinin attenuates high-fat diet-induced renal fibrosis of diabetic nephropathy. Drug Des Devel Ther 2019;13:3117-26. [PMID: 31695328 DOI: 10.2147/DDDT.S209981] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
18 Xu F, Yang J, Negishi H, Sun Y, Li D, Zhang X, Hayashi T, Gao M, Ikeda K, Ikejima T. Silibinin decreases hepatic glucose production through the activation of gut-brain-liver axis in diabetic rats. Food Funct 2018;9:4926-35. [PMID: 30178798 DOI: 10.1039/c8fo00565f] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
19 Ji T, Wang Y, Zhu Y, Gao C, Li X, Li J, Bai F, Bai S. Long noncoding RNA Gm6135 functions as a competitive endogenous RNA to regulate toll‐like receptor 4 expression by sponging miR‐203‐3p in diabetic nephropathy. J Cell Physiol 2019;234:6633-41. [DOI: 10.1002/jcp.27412] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]